AMGN vs GMED · P/E 24, rev $10.05B vs P/E 42, rev $1.55B
Amgen Inc (AMGN) versus Globus Medical (GMED) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Globus Medical (GMED) is a medical devices company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Not investment advice. Open the AMGN and GMED stock pages for the full models.
Not investment advice.